Pull to refresh
Logo
Daily Brief
Following
Why Ranks Sign Up
Federal pressure shutters pediatric gender clinics nationwide

Federal pressure shutters pediatric gender clinics nationwide

Rule Changes

HHS investigations and funding threats force hospitals to halt care even in states where it remains legal; California AG sues Rady for violating merger conditions

February 5th, 2026: STAT Analysis: 40+ Hospitals Have Paused Gender-Affirming Care

Overview

Lurie Children's Hospital, which opened the Midwest's first pediatric gender identity clinic in 2013, announced it will no longer prescribe gender-affirming medications to new patients under 18. This came days after HHS General Counsel Mike Stuart referred the hospital for federal investigation.

Lurie is one of at least 40 hospital systems that have paused or ended pediatric gender services since January 2025. Rady Children's Health, California's largest pediatric healthcare system, announced on January 23, 2026, it will stop all gender-affirming medical interventions on February 6. California Attorney General Rob Bonta sued Rady on February 3 for violating merger conditions that required it to maintain gender-affirming care through 2034.

The administration bypasses state legislatures by threatening to exclude hospitals from Medicare and Medicaid, which fund 60-70% of revenue for many children's hospitals. The threat has effectively restricted care even in California, Illinois, and other states with protective laws. A coalition of 21 states sued to block the policy, with oral arguments set for March 19, 2026.

HHS has agreed not to formally exclude hospitals until oral arguments conclude, but the investigations and proposed rules continue to drive voluntary compliance. Families sued Children's Hospital Colorado on January 21 for discrimination under state law. A federal judge ordered HHS to restore $12 million to the American Academy of Pediatrics on January 12, calling funding cuts 'retaliatory.'

Play on this story Voices Debate Predict

Key Indicators

40+
Hospitals pausing or ending care
Hospital systems that have paused, discontinued, or ended pediatric gender services since January 2025; at least 9 have stopped hormones and puberty blockers
15+
Hospitals under OIG investigation
Children's hospitals referred for HHS Inspector General investigation by General Counsel Stuart
21
States suing HHS
States plus D.C. challenging the Kennedy Declaration in federal court
27
States with existing bans
States that have enacted legislative bans on gender-affirming care for minors

Voices

Curated perspectives — historical figures and your fellow readers.

Ever wondered what historical figures would say about today's headlines?

Sign up to generate historical perspectives on this story.

Play

Exploring all sides of a story is often best achieved with Play.

Log in to play. Track your picks, climb the leaderboards. Log in Sign Up
Predict 4 ways this could play out. Contrarian picks score more — points lock when the scenario resolves. Log in to play
Timeline Five events from this story — drag them oldest to newest. Log in to play
Connections Sixteen names from the news. Find the four hidden groups of four. Log in to play

People Involved

Organizations Involved

Timeline

January 2025 February 2026

21 events Latest: February 5th, 2026 · 4 months ago Showing 8 of 21
Tap a bar to jump to that date
  1. STAT Analysis: 40+ Hospitals Have Paused Gender-Affirming Care

    Latest Analysis

    STAT News analysis finds at least 40 hospitals nationwide have paused or ceased gender-affirming care since January 2025; at least 9 have stopped hormones and puberty blockers. HHS General Counsel Stuart claims 30+ stopped 'in recent weeks' but does not name them.

  2. Rady Children's Hospital Announces End to Gender-Affirming Care

    Hospital Action

    California's largest pediatric healthcare system announces it will stop all gender-affirming medical interventions on February 6, affecting approximately 1,000 patients. Hospital reveals it is under HHS OIG investigation.

  3. Lurie Halts New Gender-Affirming Medications for Minors

    Hospital Action

    Lurie Children's Hospital announces it will no longer prescribe gender-affirming medications to patients under 18 who have not previously been treated by their team.

  4. Children's Hospital Colorado Suspends Gender Care

    Hospital Action

    Following OIG referral, hospital announces it will not write new prescriptions or renew existing prescriptions for gender-affirming care for patients under 18.

  5. Kennedy Issues 'Sex-Rejecting Procedures' Declaration

    Regulatory

    HHS Secretary Kennedy declares gender-affirming care for minors unsafe and ineffective, threatens to exclude participating hospitals from Medicare and Medicaid.

  6. CMS Proposes Rules Banning Hospital Participation

    Regulatory

    Two proposed rules would bar hospitals from Medicare/Medicaid for providing any gender-affirming care to minors, regardless of payment source. Comment period ends February 17, 2026.

  7. Mike Stuart Confirmed as HHS General Counsel

    Personnel

    Former U.S. Attorney and West Virginia State Senator Mike Stuart confirmed to lead HHS legal office.

  8. CHLA Gender Clinic Closes

    Hospital Action

    Children's Hospital Los Angeles shuts down one of the oldest and largest pediatric gender clinics in the country, leaving nearly 3,000 patients to find new providers.

  9. Children's Hospital Los Angeles Announces Clinic Closure

    Hospital Action

    CHLA announces it will close its Center for Transyouth Health and Development on July 22, citing dependence on federal funding and 'no viable path forward.'

  10. Lurie Pauses Gender-Affirming Surgeries for Minors

    Hospital Action

    Lurie Children's Hospital suspends gender-affirming surgeries for patients under 19, while continuing hormone therapy and other services.

  11. Trump Signs Executive Order on Pediatric Gender Care

    Executive Action

    Executive Order 14187, 'Protecting Children from Chemical and Surgical Mutilation,' directs agencies to restrict federal funding for gender-affirming care for individuals under 19.

Historical Context

3 moments from history that rhyme with this story — and how they unfolded.

April 2024

UK National Health Service Cass Review (2024)

Pediatrician Hilary Cass completed a four-year independent review of NHS gender services for young people. The report concluded that evidence for puberty blockers was 'weak' and recommended restricting their use to clinical trials. NHS England immediately decommissioned routine puberty blocker prescribing and closed the Tavistock gender clinic, replacing it with regional services under tighter protocols.

Then

The UK government prohibited puberty blocker prescriptions for minors outside research settings. Thousands of young people on waiting lists faced indefinite delays.

Now

The Cass Review became a reference point for policymakers worldwide seeking to restrict pediatric gender care, though medical organizations in Germany, Austria, and elsewhere disputed its methodology and conclusions.

Why this matters now

HHS cited the Cass Review in its December 2025 declaration. The UK example shows how an official evidence review can enable rapid policy change—but also how contested the underlying science remains among medical bodies internationally.

2020-2022

Sweden and Finland Restrict Pediatric Gender Care (2020-2022)

Finland's Council for Choices in Health Care concluded in 2020 that hormonal treatments for minors were experimental and should not be first-line care. Sweden followed in 2022, with the National Board of Health and Welfare finding that 'the risks of puberty blockers and gender-affirming treatment are likely to outweigh the expected benefits' and restricting treatments to research settings.

Then

Both countries shifted to psychotherapy-first approaches. Access to medical interventions for minors dropped sharply, though a small number continued receiving care under research protocols.

Now

The Nordic reversals gave political cover to restriction advocates elsewhere, while supporters of gender-affirming care noted these countries did not ban care outright and continued legal gender recognition reforms.

Why this matters now

The European precedents demonstrate that restrictions can emerge from within national health systems rather than through legislative bans. The U.S. approach combines elements of both—executive regulatory action operating alongside state-level legislation.

1988-2019

Federal Family Planning Funding Restrictions (1988-2019)

The Reagan administration's 1988 'gag rule' barred Title X family planning clinics from providing abortion referrals. Planned Parenthood and other providers faced a choice: comply and restrict counseling, or exit the federal program. The rule was rescinded by Clinton, reinstated by Trump in 2019, and rescinded again by Biden.

Then

In both eras, major providers withdrew from Title X rather than comply, reducing access to federally-funded family planning services in many regions.

Now

The repeated reversals demonstrated how executive-branch funding conditions can reshape healthcare access without legislation—but also how such policies remain vulnerable to electoral change.

Why this matters now

The current HHS strategy mirrors the Title X approach: using participation in federal health programs as leverage to restrict specific services. The family planning precedent suggests hospitals may face pressure to exit federal programs or comply, with policy durability depending on future elections.

Sources

(25)